NATIONAL HEALTHCARE CORP (NHC) Fundamental Analysis & Valuation

NYSEARCA:NHC • US6359061008

Current stock price

170.85 USD
-5.96 (-3.37%)
At close:
170.85 USD
0 (0%)
After Hours:

This NHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. NHC Profitability Analysis

1.1 Basic Checks

  • NHC had positive earnings in the past year.
  • NHC had a positive operating cash flow in the past year.
  • NHC had positive earnings in each of the past 5 years.
  • Each year in the past 5 years NHC had a positive operating cash flow.
NHC Yearly Net Income VS EBIT VS OCF VS FCFNHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

1.2 Ratios

  • NHC has a Return On Assets of 7.86%. This is amongst the best in the industry. NHC outperforms 89.00% of its industry peers.
  • NHC's Return On Equity of 11.23% is fine compared to the rest of the industry. NHC outperforms 73.00% of its industry peers.
  • NHC has a better Return On Invested Capital (7.58%) than 70.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for NHC is below the industry average of 8.74%.
  • The 3 year average ROIC (5.59%) for NHC is below the current ROIC(7.58%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.86%
ROE 11.23%
ROIC 7.58%
ROA(3y)6.55%
ROA(5y)6.26%
ROE(3y)9.66%
ROE(5y)9.38%
ROIC(3y)5.59%
ROIC(5y)4.83%
NHC Yearly ROA, ROE, ROICNHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With an excellent Profit Margin value of 7.91%, NHC belongs to the best of the industry, outperforming 88.00% of the companies in the same industry.
  • In the last couple of years the Profit Margin of NHC has grown nicely.
  • NHC's Operating Margin of 8.46% is fine compared to the rest of the industry. NHC outperforms 75.00% of its industry peers.
  • In the last couple of years the Operating Margin of NHC has declined.
  • NHC's Gross Margin of 39.31% is fine compared to the rest of the industry. NHC outperforms 71.00% of its industry peers.
  • In the last couple of years the Gross Margin of NHC has remained more or less at the same level.
Industry RankSector Rank
OM 8.46%
PM (TTM) 7.91%
GM 39.31%
OM growth 3Y47.3%
OM growth 5Y-2.21%
PM growth 3Y56.39%
PM growth 5Y14.19%
GM growth 3Y2.23%
GM growth 5Y-1.42%
NHC Yearly Profit, Operating, Gross MarginsNHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. NHC Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NHC is destroying value.
  • Compared to 1 year ago, NHC has more shares outstanding
  • NHC has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, NHC has an improved debt to assets ratio.
NHC Yearly Shares OutstandingNHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
NHC Yearly Total Debt VS Total AssetsNHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • NHC has an Altman-Z score of 5.80. This indicates that NHC is financially healthy and has little risk of bankruptcy at the moment.
  • NHC has a better Altman-Z score (5.80) than 88.00% of its industry peers.
  • The Debt to FCF ratio of NHC is 0.27, which is an excellent value as it means it would take NHC, only 0.27 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.27, NHC belongs to the top of the industry, outperforming 91.00% of the companies in the same industry.
  • NHC has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • NHC's Debt to Equity ratio of 0.03 is amongst the best of the industry. NHC outperforms 81.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.27
Altman-Z 5.8
ROIC/WACC0.86
WACC8.83%
NHC Yearly LT Debt VS Equity VS FCFNHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • NHC has a Current Ratio of 1.82. This is a normal value and indicates that NHC is financially healthy and should not expect problems in meeting its short term obligations.
  • NHC has a Current ratio of 1.82. This is in the better half of the industry: NHC outperforms 76.00% of its industry peers.
  • A Quick Ratio of 1.79 indicates that NHC should not have too much problems paying its short term obligations.
  • NHC has a Quick ratio of 1.79. This is in the better half of the industry: NHC outperforms 77.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.79
NHC Yearly Current Assets VS Current LiabilitesNHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. NHC Growth Analysis

3.1 Past

  • NHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.38%, which is quite good.
  • The Earnings Per Share has been growing by 23.00% on average over the past years. This is a very strong growth
  • The Revenue has grown by 16.09% in the past year. This is quite good.
  • Measured over the past years, NHC shows a quite strong growth in Revenue. The Revenue has been growing by 8.10% on average per year.
EPS 1Y (TTM)17.38%
EPS 3Y74.12%
EPS 5Y23%
EPS Q2Q%306.54%
Revenue 1Y (TTM)16.09%
Revenue growth 3Y11.81%
Revenue growth 5Y8.1%
Sales Q2Q%4.65%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NHC Yearly Revenue VS EstimatesNHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

Find the best growth stocksShow best growing peers

3

4. NHC Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 22.28, the valuation of NHC can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of NHC indicates a somewhat cheap valuation: NHC is cheaper than 64.00% of the companies listed in the same industry.
  • NHC's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.78.
Industry RankSector Rank
PE 22.28
Fwd PE N/A
NHC Price Earnings VS Forward Price EarningsNHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • NHC's Enterprise Value to EBITDA ratio is in line with the industry average.
  • NHC's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. NHC is cheaper than 63.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.86
EV/EBITDA 13.67
NHC Per share dataNHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • NHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.97
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. NHC Dividend Analysis

5.1 Amount

  • NHC has a Yearly Dividend Yield of 1.59%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.50, NHC pays a better dividend. On top of this NHC pays more dividend than 89.00% of the companies listed in the same industry.
  • NHC's Dividend Yield is comparable with the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 1.59%

5.2 History

  • The dividend of NHC has a limited annual growth rate of 3.74%.
  • NHC has paid a dividend for at least 10 years, which is a reliable track record.
  • NHC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.74%
Div Incr Years12
Div Non Decr Years12
NHC Yearly Dividends per shareNHC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • NHC pays out 32.25% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of NHC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP32.25%
EPS Next 2YN/A
EPS Next 3YN/A
NHC Yearly Income VS Free CF VS DividendNHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M
NHC Dividend Payout.NHC Dividend Payout, showing the Payout Ratio.NHC Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NHC Fundamentals: All Metrics, Ratios and Statistics

NATIONAL HEALTHCARE CORP

NYSEARCA:NHC (4/10/2026, 8:04:00 PM)

After market: 170.85 0 (0%)

170.85

-5.96 (-3.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)05-01
Inst Owners64.91%
Inst Owner Change0%
Ins Owners7.03%
Ins Owner Change0.92%
Market Cap2.66B
Revenue(TTM)1.52B
Net Income(TTM)120.02M
Analysts60
Price TargetN/A
Short Float %4.62%
Short Ratio6.23
Dividend
Industry RankSector Rank
Dividend Yield 1.59%
Yearly Dividend2.5
Dividend Growth(5Y)3.74%
DP32.25%
Div Incr Years12
Div Non Decr Years12
Ex-Date03-31
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 22.28
Fwd PE N/A
P/S 1.75
P/FCF 17.86
P/OCF 14.35
P/B 2.48
P/tB 3.02
EV/EBITDA 13.67
EPS(TTM)7.67
EY4.49%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)9.56
FCFY5.6%
OCF(TTM)11.91
OCFY6.97%
SpS97.67
BVpS68.78
TBVpS56.53
PEG (NY)N/A
PEG (5Y)0.97
Graham Number108.95
Profitability
Industry RankSector Rank
ROA 7.86%
ROE 11.23%
ROCE 10.08%
ROIC 7.58%
ROICexc 9.49%
ROICexgc 11.67%
OM 8.46%
PM (TTM) 7.91%
GM 39.31%
FCFM 9.79%
ROA(3y)6.55%
ROA(5y)6.26%
ROE(3y)9.66%
ROE(5y)9.38%
ROIC(3y)5.59%
ROIC(5y)4.83%
ROICexc(3y)6.91%
ROICexc(5y)6.01%
ROICexgc(3y)8.5%
ROICexgc(5y)7.43%
ROCE(3y)7.43%
ROCE(5y)6.42%
ROICexgc growth 3Y57.26%
ROICexgc growth 5Y3.29%
ROICexc growth 3Y57.83%
ROICexc growth 5Y-0.34%
OM growth 3Y47.3%
OM growth 5Y-2.21%
PM growth 3Y56.39%
PM growth 5Y14.19%
GM growth 3Y2.23%
GM growth 5Y-1.42%
F-Score9
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.27
Debt/EBITDA 0.19
Cap/Depr 81.14%
Cap/Sales 2.4%
Interest Coverage 18.26
Cash Conversion 106.81%
Profit Quality 123.85%
Current Ratio 1.82
Quick Ratio 1.79
Altman-Z 5.8
F-Score9
WACC8.83%
ROIC/WACC0.86
Cap/Depr(3y)71.08%
Cap/Depr(5y)76.94%
Cap/Sales(3y)2.32%
Cap/Sales(5y)2.68%
Profit Quality(3y)108.92%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.38%
EPS 3Y74.12%
EPS 5Y23%
EPS Q2Q%306.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.09%
Revenue growth 3Y11.81%
Revenue growth 5Y8.1%
Sales Q2Q%4.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y42.78%
EBIT growth 3Y64.7%
EBIT growth 5Y5.71%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y86.48%
FCF growth 3YN/A
FCF growth 5Y-3.9%
OCF growth 1Y72.48%
OCF growth 3Y176.64%
OCF growth 5Y-1.86%

NATIONAL HEALTHCARE CORP / NHC Fundamental Analysis FAQ

What is the fundamental rating for NHC stock?

ChartMill assigns a fundamental rating of 6 / 10 to NHC.


Can you provide the valuation status for NATIONAL HEALTHCARE CORP?

ChartMill assigns a valuation rating of 3 / 10 to NATIONAL HEALTHCARE CORP (NHC). This can be considered as Overvalued.


Can you provide the profitability details for NATIONAL HEALTHCARE CORP?

NATIONAL HEALTHCARE CORP (NHC) has a profitability rating of 7 / 10.


What is the valuation of NATIONAL HEALTHCARE CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for NATIONAL HEALTHCARE CORP (NHC) is 22.28 and the Price/Book (PB) ratio is 2.48.


Can you provide the financial health for NHC stock?

The financial health rating of NATIONAL HEALTHCARE CORP (NHC) is 7 / 10.